OncoGenomX ^Company

OncoGenomX is a Swiss company that develops treatment guidance software, with their first product being PredictionStar. This software helps breast cancer doctors determine the optimal treatment for lasting metastasis prevention, with an 85% chance of determining the best treatment option. OncoGenomX's core competency lies in the analysis and interpretation of digital clinical images, digital histology images, and tumor and blood gene testing results to predict pharmacological weak points. Their mission is to become the best treatment guidance software and make durable metastasis prevention a reality for all patients.